Diabetes Clinical Trials

Showing 7841-7860 of 7,874 trials

A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.

NCT00283218

The hypothesis is that an optimal formulation of fast acting and intermediary acting insulin analogues will improve post prandial glycaemic control in patients with type 1 diabetes. OBJECTIVE: The objective is to describe pharmacodynamic (PD) and pharmacokinetic (PK) profiles of Insulin Aspart (IAsp), Biphasic Insulin Aspart (BIAsp) 30, 50 and 70 for a period of 12 hours following a standard test meal on four days respectively in subjects with type 1 diabetes.

Type 1 Diabetes

University of Aarhus24 participantsStarted Jan 2006

Aarhus, C, Denmark

COMPLETEDNA

Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy

NCT00361023

Angiotensin type-1 receptor (AT1R) blockers (ARBs) have been recognized recently as regulators of glucose and lipid metabolism in adipocytes and adipose tissue.Moreover telmisartan and irbesartan have been recognized recently as regulators of glucose metabolism. For ARB losartan, the results were controversial. To confirm its effect on glucose metabolism, we designed and performed a prospective, randomized and controlled study in subjects with type 2 diabetes and nephropathy.

Type 2 DiabetesDiabetic Nephropathy

Shanghai Jiao Tong University School of Medicine25 participantsStarted Jan 2006

COMPLETEDPhase 2

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

NCT00065312

The purpose of this study is to determine if an investigational drug is safe and efficacious for poorly controlled type 2 diabetes mellitus.

Diabetes Mellitus, Non-Insulin-Dependent

Eli Lilly and Company

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Peoria, Arizona, United States +39 more locations

A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.

Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

Related Searches

A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes

Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study

Lantus in Prediabetes

Irbesartan in Type 2 Diabetes

A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM

Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction

Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease

Life Style Modifications Prevents Type 2 Diabetes in Asian Indians

Doctor-Patient Communication in Spanish

Trial of New Dietary Treatment of Diabetes

Diagnosis of Insulin Resistance: 13C-Glucose Breath Test Vs HOMA Index.

Ability of a Tea Leaf Extracts Preparation to Slow Down Carbohydrate and Fat Absorption

Use of a Portion Control Food Tool to Induce Weight Loss in Obese Type 2 Diabetics.

Shared Online Health Records for Patient Safety and Care

hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure

Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics

Diabetes Knowledge Assessment